Rituxan
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Abstract In the 1950s, the discovery of autoantibodies produced by B cells seemed to provide a compelling mechanism underlying…
An 86-year-old man presented in October of 2001 with sudden loss of bowel and bladder control accompanied by bilateral lower…
Disease relapse occurs in 50% or more of patients who are autografted for relapsed or refractory lymphoma (NHL) or Hodgkin's…
In 1997, a chimeric anti-CD20 monoclonal antibody (mAb) (Rituxan) was approved for the treatment of low-grade/follicular B-cell…
Numerous studies have reported that monoclonal antibody (mAb) FMC7 detects an antigen present on only a subset of circulating B…
The objective of this multiinstitutional study was to evaluate the safety and efficacy of rituximab at standard four weekly doses…